{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T17:49:00Z","timestamp":1791308940209,"version":"4.3.1"},"reference-count":37,"publisher":"American Society for Microbiology","issue":"5","license":[{"start":{"date-parts":[[2004,5,1]],"date-time":"2004-05-01T00:00:00Z","timestamp":1083369600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.asm.org\/non-commercial-tdm-license"}],"content-domain":{"domain":["journals.asm.org"],"crossmark-restriction":true},"short-container-title":["Antimicrob Agents Chemother"],"published-print":{"date-parts":[[2004,5]]},"abstract":"<jats:title>ABSTRACT<\/jats:title>\n          <jats:p>\n            Previous studies with beta-lactamase-negative, ampicillin-resistant (BLNAR)\n            <jats:italic>Haemophilus influenzae<\/jats:italic>\n            from Japan, France, and North America indicate that mutations in\n            <jats:italic>ftsI<\/jats:italic>\n            encoding PBP3 confer ampicillin MICs of 1 to 4 \u03bcg\/ml. Several BLNAR strains with ampicillin MICs of 4 to 16 \u03bcg\/ml recently isolated from North America were studied. Pulsed-field gel electrophoresis identified 12 unique BLNAR strains; sequencing of their\n            <jats:italic>ftsI<\/jats:italic>\n            transpeptidase domains identified 1 group I and 11 group II mutants, as designated previously (K. Ubukata, Y. Shibasaki, K. Yamamoto, N. Chiba, K. Hasegawa, Y. Takeuchi, K. Sunakawa, M. Inoue, and M. Konno, Antimicrob. Agents Chemother.\n            <jats:bold>45:<\/jats:bold>\n            1693-1699, 2001). Geometric mean ampicillin MICs for several clinical isolates were 8 to 10.56 \u03bcg\/ml. Replacement of the\n            <jats:italic>ftsI<\/jats:italic>\n            gene in\n            <jats:italic>H. influenzae<\/jats:italic>\n            Rd with the intact\n            <jats:italic>ftsI<\/jats:italic>\n            from several clinical isolates resulted in integrants with typical BLNAR geometric mean ampicillin MICs of 1.7 to 2.2 \u03bcg\/ml. Cloning and purification of His-tagged PBP3 from three clinical BLNAR strains showed significantly reduced Bocillin binding compared to that of PBP3 from strain Rd. Based on these data, changes in PBP3 alone could not account for the high ampicillin MICs observed for these BLNAR isolates. In an effort to determine the presence of additional mechanism(s) of ampicillin resistance, sequencing of the transpeptidase regions of\n            <jats:italic>pbp1a<\/jats:italic>\n            , -\n            <jats:italic>1b<\/jats:italic>\n            , and -\n            <jats:italic>2<\/jats:italic>\n            was performed. While numerous changes were observed compared to the sequences from Rd, no consistent pattern correlating with high-level ampicillin resistance was apparent. Additional analysis of the resistant BLNAR strains revealed frame shift insertions in\n            <jats:italic>acrR<\/jats:italic>\n            for all four high-level, ampicillin-resistant isolates.\n            <jats:italic>acrR<\/jats:italic>\n            was intact for all eight low-level ampicillin-resistant and four ampicillin-susceptible strains tested. A knockout of\n            <jats:italic>acrB<\/jats:italic>\n            made in one clinical isolate (initial mean ampicillin MIC of 10.3 \u03bcg\/ml) lowered the ampicillin MIC to 3.67 \u03bcg\/ml, typical for BLNAR strains. These studies illustrate that BLNAR strains with high ampicillin MICs exist that have combined resistance mechanisms in PBP3 and in the AcrAB efflux pump.\n          <\/jats:p>","DOI":"10.1128\/aac.48.5.1630-1639.2004","type":"journal-article","created":{"date-parts":[[2004,4,22]],"date-time":"2004-04-22T19:58:16Z","timestamp":1082663896000},"page":"1630-1639","update-policy":"https:\/\/doi.org\/10.1128\/asmj-crossmark-policy-page","source":"Crossref","is-referenced-by-count":96,"title":["Genetic and Molecular Characterization of \u03b2-Lactamase-Negative Ampicillin-Resistant\n            <i>Haemophilus influenzae<\/i>\n            with Unusually High Resistance to Ampicillin"],"prefix":"10.1128","volume":"48","author":[{"given":"Frank S.","family":"Kaczmarek","sequence":"first","affiliation":[{"name":"Department of Immunology and Infectious Disease"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas D.","family":"Gootz","sequence":"additional","affiliation":[{"name":"Department of Immunology and Infectious Disease"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fadia","family":"Dib-Hajj","sequence":"additional","affiliation":[{"name":"Department of Immunology and Infectious Disease"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenchi","family":"Shang","sequence":"additional","affiliation":[{"name":"Department of Immunology and Infectious Disease"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shawn","family":"Hallowell","sequence":"additional","affiliation":[{"name":"Department of Molecular Sciences, Pfizer Global Research and Development, Groton, Connecticut 06340"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Melissa","family":"Cronan","sequence":"additional","affiliation":[{"name":"Department of Molecular Sciences, Pfizer Global Research and Development, Groton, Connecticut 06340"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"235","reference":[{"key":"e_1_3_2_2_2","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1007\/s00232-002-1008-6","volume":"189","year":"2002","unstructured":"Arbing, M. A., J. W. Hanrahan, and J. W. Coulton. 2002. Altered channel properties of porins from Haemophilus influenzae: isolates from cystic fibrosis patients. J. Membr. Biol.189:131-141.","journal-title":"J. Membr. Biol."},{"key":"e_1_3_2_3_2","doi-asserted-by":"publisher","DOI":"10.1016\/0076-6879(91)04016-H"},{"key":"e_1_3_2_4_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.45.5.1585-1588.2001"},{"key":"e_1_3_2_5_2","first-page":"1273","volume":"133","year":"1987","unstructured":"Burns, J. L., and A. L. Smith. 1987. A major outer-membrane protein functions as a porin in Haemophilus influenzae. J. Gen. Microbiol.133:1273-1277.","journal-title":"J. Gen. Microbiol."},{"key":"e_1_3_2_6_2","doi-asserted-by":"publisher","DOI":"10.1128\/jcm.24.3.330-332.1986"},{"key":"e_1_3_2_7_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.36.7.1504"},{"key":"e_1_3_2_8_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.46.7.2208-2218.2002"},{"key":"e_1_3_2_9_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.41.2.292"},{"key":"e_1_3_2_10_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2958.1992.tb01384.x"},{"key":"e_1_3_2_11_2","doi-asserted-by":"publisher","DOI":"10.1007\/s002849900349"},{"key":"e_1_3_2_12_2","doi-asserted-by":"publisher","DOI":"10.1089\/107662903764736337"},{"key":"e_1_3_2_13_2","doi-asserted-by":"publisher","DOI":"10.1086\/339362"},{"key":"e_1_3_2_14_2","doi-asserted-by":"publisher","DOI":"10.1128\/JCM.40.3.1063-1066.2002"},{"key":"e_1_3_2_15_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.38.8.1742"},{"key":"e_1_3_2_16_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2958.1996.357881.x"},{"key":"e_1_3_2_17_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.17.1.80"},{"key":"e_1_3_2_18_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.44.5.1387-1390.2000"},{"key":"e_1_3_2_19_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.46.12.3984-3986.2002"},{"key":"e_1_3_2_20_2","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/162.5.1118"},{"key":"e_1_3_2_21_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.26.2.235"},{"key":"e_1_3_2_22_2","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.274.27.19175"},{"key":"e_1_3_2_23_2","unstructured":"National Committee for Clinical Laboratory Standards. 2002. Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically. Approved standard 5th ed. NCCLS document M100-S12. National Committee for Clinical Laboratory Standards Wayne Pa."},{"key":"e_1_3_2_24_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0732-8893(99)00147-9"},{"key":"e_1_3_2_25_2","doi-asserted-by":"publisher","DOI":"10.1128\/jb.178.1.306-308.1996"},{"key":"e_1_3_2_26_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.47.3.1017-1022.2003"},{"key":"e_1_3_2_27_2","doi-asserted-by":"publisher","DOI":"10.1128\/JCM.40.2.660-662.2002"},{"key":"e_1_3_2_28_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.36.11.2569"},{"key":"e_1_3_2_29_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.46.8.2640-2643.2002"},{"key":"e_1_3_2_30_2","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/S0924-8579(99)00112-0","volume":"13","year":"1999","unstructured":"Richter, S. S., A. B. Bruegemann, H. K. Huynh, P. R. Rhomberg, E. M. Wingert, R. Flamm, and G. V. Doern. 1999. A 1997-1998 national surveillance study: Moraxella catarrhalis and Haemophilus influenzae antimicrobial resistance in 34 US institutions. Int. J. Antimicrob. Agents13:99-107.","journal-title":"Int. J. Antimicrob. Agents"},{"key":"e_1_3_2_31_2","first-page":"2775","volume":"135","year":"1989","unstructured":"Rowji, P., R. Gromkova, and H. Koornhof. 1989. Genetic transformation in encapsulated clinical isolates of Haemophilus influenzae type b. J. Gen. Microbiol.135:2775-2782.","journal-title":"J. Gen. Microbiol."},{"key":"e_1_3_2_32_2","doi-asserted-by":"publisher","DOI":"10.1128\/JCM.37.7.2142-2147.1999"},{"key":"e_1_3_2_33_2","doi-asserted-by":"publisher","DOI":"10.1128\/jb.179.21.6855-6857.1997"},{"key":"e_1_3_2_34_2","doi-asserted-by":"publisher","DOI":"10.1007\/s10156-002-0209-3"},{"key":"e_1_3_2_35_2","doi-asserted-by":"publisher","DOI":"10.1007\/s101560200006"},{"key":"e_1_3_2_36_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.45.6.1693-1699.2001"},{"key":"e_1_3_2_37_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.43.5.1124"},{"key":"e_1_3_2_38_2","doi-asserted-by":"publisher","DOI":"10.1128\/jb.179.15.4901-4908.1997"}],"container-title":["Antimicrobial Agents and Chemotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.asm.org\/doi\/pdf\/10.1128\/AAC.48.5.1630-1639.2004","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.asm.org\/doi\/pdf\/10.1128\/AAC.48.5.1630-1639.2004","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,2,21]],"date-time":"2022-02-21T18:15:44Z","timestamp":1645467344000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.asm.org\/doi\/10.1128\/AAC.48.5.1630-1639.2004"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,5]]},"references-count":37,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2004,5]]}},"alternative-id":["10.1128\/AAC.48.5.1630-1639.2004"],"URL":"https:\/\/doi.org\/10.1128\/aac.48.5.1630-1639.2004","relation":{},"ISSN":["0066-4804","1098-6596"],"issn-type":[{"value":"0066-4804","type":"print"},{"value":"1098-6596","type":"electronic"}],"subject":[],"published":{"date-parts":[[2004,5]]},"assertion":[{"value":"2003-08-19","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2004-01-09","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2004-05-01","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}